Cell-based Vaccine Production - Creative Biolabs
Cultivation of Vero Cells in Packed-Bed Bioreactors
Designing cell lines for viral vaccine production: Where do we stand? - Genzel - 2015 - Biotechnology Journal - Wiley Online Library
A whole virion vaccine for COVID-19 produced via a novel inactivation method: results from animal challenge model studies | bioRxiv
Peering into the production process of China's inactivated COVID-19 vaccine - Xinhua | English.news.cn
Enhancing virus production using knockout Vero cell lines
Getting a Grip on Influenza: The Pursuit of a Universal Vaccine (Part 2)
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action | npj Vaccines
Development of an inactivated vaccine candidate for SARS-CoV-2 | Science
Enhancing viral vaccine production using engineered knockout vero cell lines – A second look - ScienceDirect
Peering into the production process of China's inactivated COVID-19 vaccine - Xinhua | English.news.cn
Role of Cell Culture Technology in new Vaccine Development
Impact Of A Chemically Defined Medium For Vero Cells Cultivation And Virus Production For Vaccine Applications
A cell-based backup to speed up pandemic influenza vaccine production: Trends in Microbiology
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates | npj Vaccines
GMP manufacturing of Vvax001, a therapeutic anti-HPV vaccine based on recombinant viral particles - ScienceDirect
Vero Cell Cultivation for Vaccine Production
Vero Cell-based Vaccine Production: Cell lines, Media and Bioreactor Options - BioProcess InternationalBioProcess International
Untitled
Vaccines | Free Full-Text | Optimization of Vero Cells Grown on a Polymer Fiber Carrier in a Disposable Bioreactor for Inactivated Coxsackievirus A16 Vaccine Development | HTML
Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media - ScienceDirect
Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet
Chinese Citizens Are Already Receiving a Coronavirus Vaccine | The New Yorker
How the Sinopharm Covid-19 Vaccine Works - The New York Times
High-Density Vero Cell Perfusion Culture
